Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jose Felipe Dos SantosfiledCriticalJose Felipe Dos Santos
Priority to BR9801337-8ApriorityCriticalpatent/BR9801337A/en
Publication of BR9801337ApublicationCriticalpatent/BR9801337A/en
<B>DOSADOR DE RAçãO PARA PEIXES<D>. A presente invenção tem como finalidade principal eliminar os transtornos e preocupações diárias quanto à alimentação de peixe, eliminando também e principalmente as preocupações da necessidade prolongada da ausência dos criadores (moradores) em relação à alimentação do mesmo. Ficando apenas a tarefa diária de contemplar a beleza e o visual magnífico que nos proporcionam.<B> FISH FEEDING DOSER <D>. The main purpose of the present invention is to eliminate the inconvenience and daily concerns regarding fish feeding, also eliminating and especially the concerns of the prolonged need for the absence of breeders (residents) in relation to their feeding. All that remains is the daily task of contemplating the beauty and the magnificent look they provide us.
BR9801337-8A1998-03-111998-03-11
Fish feed dispenser.
BR9801337A
(en)
Combination therapeutic product, pharmaceutical composition, use of a combination therapeutic product, and method for the treatment or prophylaxis of prostate cancer
THE USE OF 17 ß -(N-TERT-BUTYLCARBAMOYIL)-4-AZA-5-ALPHA-ANDROST-1-ENE-3-ONE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ANDROGENIC ALOPECIA
Pharmaceutical product and daily pharmaceutical dose for administration to a patient, dose regimen providing an anti-androgenic effect and an antiestrogenic effect on a patient, use of a compound and tamoxifen or a pharmaceutically acceptable salt or solvate thereof, and, method for providing an anti-androgenic effect in a patient
Combination of an endothelin antagonist, pharmaceutical preparation, process for preparing a pharmaceutical preparation, and use of a combination of a beta receptor blocker and an endothelin antagonist